SIBIONO Trademark
Trademark Overview
On Thursday, October 12, 2017, a trademark application was filed for SIBIONO with the United States Patent and Trademark Office. The USPTO has given the SIBIONO trademark a serial number of 87643007. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 29, 2024. This trademark is owned by Shenzhen Sibiono GeneTech Co., Ltd.. The SIBIONO trademark is filed in the Pharmaceutical Products category with the following description:
Bacterial poisons; Diagnostic preparations for medical purposes; Medicinal herbal extracts for medical purposes; Pharmaceutical preparations, namely, antivirals; Vaccines; Cardiotonics; Cultures of microorganisms for medical or veterinary use; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders
General Information
| Serial Number | 87643007 |
| Word Mark | SIBIONO |
| Filing Date | Thursday, October 12, 2017 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, November 29, 2024 |
| Registration Number | 5469292 |
| Registration Date | Tuesday, May 15, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 27, 2018 |
Trademark Statements
| Goods and Services | Bacterial poisons; Diagnostic preparations for medical purposes; Medicinal herbal extracts for medical purposes; Pharmaceutical preparations, namely, antivirals; Vaccines; Cardiotonics; Cultures of microorganisms for medical or veterinary use; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, June 19, 2017 |
| First Use In Commerce Date | Monday, June 19, 2017 |
Trademark Owner History
| Party Name | Shenzhen Sibiono GeneTech Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Shenzhen 518057
CN |
| Party Name | Shenzhen Sibiono GeneTech Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Shenzhen 518057
CN |
| Party Name | Shenzhen Sibiono GeneTech Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Shenzhen 518057
CN |
Trademark Events
| Event Date | Event Description |
| Monday, October 16, 2017 | NEW APPLICATION ENTERED |
| Friday, October 20, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 22, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, January 24, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 7, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 27, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 27, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 15, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Monday, May 15, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, November 29, 2024 | CANCELLED SEC. 8 (6-YR) |
